| Serial Number | 97292956 |
| Word Mark | PRECEDE BIO |
| Filing Date | Thursday, March 3, 2022 |
| Status | 601 - ABANDONED - EXPRESS |
| Status Date | Tuesday, February 6, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | medical testing and diagnostic services; clinical pathology services; medical analysis services for diagnostic and treatment purposes relating to the treatment of persons; medical testing for diagnostic or treatment purposes in the field of pathology relating to the treatment of persons; medical diagnostic testing, monitoring and reporting services; diagnostics services, namely, the recommendation of medical treatment for identified disease states |
| Disclaimer with Predetermined Text | "BIO" |
| Goods and Services | Software as a service (SAAS) services featuring software for inputting, accessing, viewing, processing and analyzing medical data; data as a service (DAAS) services featuring software for the provision of data, namely, for inputting, accessing, viewing, processing and analyzing medical data; computer services, namely, providing data as a service (DaaS) services featuring software for analyzing and managing data for purposes of drug development and discovery; computer services, namely, the provision of data as a service in the pharmaceuticals and healthcare fields for analyzing medical research data information in relation to pharmaceutical drug discovery and drug development; pharmaceutical research and development; pharmaceutical drug development and drug discovery services; medical research and scientific research; providing medical and scientific research information in the field of pharmaceuticals' research and development of technology in the field of pharmaceuticals; biomedical research services; product development in the field of pharmaceuticals, namely, the development of preclinical and therapeutic product |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, March 8, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, March 8, 2022 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | PRECEDE BIOSCIENCES, INC. |
| Party Type | 11 - New Owner Before Publication |
| Legal Entity Type | 03 - Corporation |
| Address | BOSTON, MA 02116 |
| Party Name | Nuscan Diagnostics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Boston, MA 02116 |
| Event Date | Event Description |
| Tuesday, February 6, 2024 | ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT |
| Tuesday, February 6, 2024 | ABANDONMENT - EXPRESS MAILED |
| Monday, January 29, 2024 | TEAS EXPRESS ABANDONMENT RECEIVED |
| Friday, October 27, 2023 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Friday, October 27, 2023 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Friday, July 28, 2023 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Friday, July 28, 2023 | FINAL REFUSAL E-MAILED |
| Friday, July 28, 2023 | FINAL REFUSAL WRITTEN |
| Wednesday, July 26, 2023 | DIVISIONAL PROCESSING COMPLETE |
| Tuesday, May 30, 2023 | DIVISIONAL REQUEST RECEIVED |
| Tuesday, July 25, 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Wednesday, May 31, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, May 30, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, May 30, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, May 30, 2023 | TEAS REQUEST TO DIVIDE RECEIVED |
| Thursday, March 2, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, March 2, 2023 | NON-FINAL ACTION E-MAILED |
| Thursday, March 2, 2023 | NON-FINAL ACTION WRITTEN |
| Wednesday, March 1, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, February 28, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, February 28, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, February 8, 2023 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Tuesday, August 30, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, August 30, 2022 | NON-FINAL ACTION E-MAILED |
| Tuesday, August 30, 2022 | NON-FINAL ACTION WRITTEN |
| Monday, August 29, 2022 | ASSIGNED TO EXAMINER |
| Tuesday, March 8, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, March 7, 2022 | NEW APPLICATION ENTERED |